Login
Companies $XRAY
$9.00 +$0.05 (0.58%) After hours
DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

dentsplysirona.com

What Do They Do?

Sells dental equipment and products, including digital tools, to dental professionals, and continence-care products to patients and medical providers.

How Do They Make Money?

Customers pay mainly for dental equipment and dental and healthcare consumables when products ship, or when destination terms require delivery; support and maintenance contracts and some warranties bring in money over the contract period or as services are provided.

revenue
SegmentShareRevenue
Connected Technology Solutions
Sold outright

28%
FY2022: 31%
Essential Dental Solutions
Sold outright

40%
FY2022: 36%
Orthodontic and Implant Solutions
Sold outright

23%
FY2022: 26%
Wellspect Healthcare
Sold outright
8.8%
FY2022: 6.9%

Who Are Their Customers?

Dental consumables and technology and equipment products mostly go through third-party distributors, while some endodontic products, implants and orthodontic aligners are sold directly to dental laboratories or professionals in some markets. Continence products mainly go to medical-supply distributors, with the rest sold directly to patients and medical providers.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2024: no customer at 10% or more of revenue

Do Revenues Turn Into Profits?

Not on paper. It lost $598M in FY2025, but brought in more cash than it spent: $104M of free cash flow.

Operating income, FY2025
−11% of revenue
▲ +52% (Loss) vs FY2024 (−$879M, −23%)
Net income, FY2025
−16% of revenue
▲ +34% (Loss) vs FY2024 (−$910M, −24%)
Free cash flow, FY2025
3% of revenue
▼ −63% vs FY2024 ($281M, 7%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −8%
vs $904M in Q3 FY2025
Net income
▲ +100% (Loss)
vs −$427M in Q3 FY2025
Essential Dental Solutions share of revenue vs 39.5% in Q3 FY2025
  • Jun 11, 2026 Company appoints John C. Fortson as CFO He is due to take the role on July 20, 2026.
  • May 5, 2026 Company maintains net sales and adjusted EPS outlook The company maintains 2026 net sales guidance of $3.5 billion to $3.6 billion and adjusted EPS guidance of $1.40 to $1.50.

Shrinking. Revenue fell 13% in 4 years, from $4.2B in FY2021 to $3.7B in FY2025, about 3% a year.

Expanded continence care The older report describes healthcare products as urology catheters and other consumables; the latest describes solutions for urinary and bowel management.

Byte's direct-to-consumer offering ended for new patients The older report describes Byte as a direct-to-consumer aligner business; the latest says it stopped offering Byte to new patients, while continuing support for some patients already in treatment.

Revenue over time
Connected Technology Solutions Essential Dental Solutions Orthodontic and Implant Solutions Wellspect Healthcare
$5B$2.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support